Shares of Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) rose 0.6% during mid-day trading on Tuesday . The company traded as high as $1.58 and last traded at $1.56. Approximately 83,368 shares traded hands during trading, a decline of 18% from the average daily volume of 101,227 shares. The stock had previously closed at $1.55.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a "buy" rating and set a $4.00 price objective on shares of Vivani Medical in a research note on Monday, May 19th.
Check Out Our Latest Analysis on VANI
Vivani Medical Trading Up 0.6%
The company has a market capitalization of $95.38 million, a price-to-earnings ratio of -3.74 and a beta of 2.89. The stock's 50 day moving average price is $1.28 and its 200 day moving average price is $1.16.
Vivani Medical (NASDAQ:VANI - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). On average, research analysts expect that Vivani Medical, Inc. will post -0.41 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Wealthedge Investment Advisors LLC bought a new position in shares of Vivani Medical during the fourth quarter worth approximately $43,000. Jane Street Group LLC bought a new position in Vivani Medical in the fourth quarter valued at approximately $66,000. Northern Trust Corp increased its stake in Vivani Medical by 19.1% in the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company's stock valued at $83,000 after acquiring an additional 11,540 shares during the last quarter. Finally, Connective Capital Management LLC increased its stake in Vivani Medical by 796.2% in the first quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock valued at $170,000 after acquiring an additional 144,010 shares during the last quarter. 6.78% of the stock is owned by institutional investors.
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access